Ocugen
Ocugen develops modifier gene therapies for blindness diseases including inherited retinal diseases, retinitis pigmentosa, Stargardt disease, and geographic atrophy.
8-KSep 23Latest SEC filing, period to Sep 21
Sep 10Latest story
Sign inSign inOcugen develops modifier gene therapies for blindness diseases including inherited retinal diseases, retinitis pigmentosa, Stargardt disease, and geographic atrophy.